Variant report

Variant	nsv978819
Chromosome Location	chr19:41589889-41601315
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:48)
CpG islands
(count:490)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:48 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr19:41595895-41596235	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr19:41595889-41596057	A549	lung:	n/a	n/a
3	CTCF	chr19:41595785-41596233	A549	lung:	n/a	n/a
4	CTCF	chr19:41595897-41596171	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr19:41592628-41592736	GM13976	blood:	n/a	n/a
6	CTCF	chr19:41595855-41596157	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr19:41600187-41600224	Spleen_OC	spleen:	n/a	n/a
8	CTCF	chr19:41595968-41596090	A549	lung:	n/a	n/a
9	CTCF	chr19:41598620-41598770	MCF-7	breast:	n/a	n/a
10	CTCF	chr19:41596020-41596170	HEK293	kidney:	n/a	n/a
11	CTCF	chr19:41595889-41596117	A549	lung:	n/a	n/a
12	CTCF	chr19:41595840-41596144	K562	blood:	n/a	n/a
13	CTCF	chr19:41595846-41596186	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr19:41595899-41596096	K562	blood:	n/a	n/a
15	CTCF	chr19:41595915-41596051	K562	blood:	n/a	n/a
16	E2F6	chr19:41595814-41596322	H1-hESC	embryonic stem cell:	n/a	chr19:41596124-41596136 chr19:41596289-41596301
17	E2F6	chr19:41595751-41596384	H1-hESC	embryonic stem cell:	n/a	chr19:41596124-41596136 chr19:41596289-41596301
18	EGR1	chr19:41595945-41596263	H1-hESC	embryonic stem cell:	n/a	n/a
19	EGR1	chr19:41595828-41596034	K562	blood:	n/a	chr19:41595928-41595937 chr19:41595927-41595940 chr19:41595927-41595940 chr19:41595927-41595940
20	EGR1	chr19:41595759-41596279	H1-hESC	embryonic stem cell:	n/a	chr19:41595928-41595937 chr19:41595927-41595940 chr19:41595927-41595940 chr19:41595927-41595940
21	EGR1	chr19:41595861-41595992	K562	blood:	n/a	chr19:41595928-41595937 chr19:41595927-41595940 chr19:41595927-41595940 chr19:41595927-41595940
22	ELF1	chr19:41590272-41590477	K562	blood:	n/a	chr19:41590340-41590353
23	GABPA	chr19:41595916-41596187	H1-hESC	embryonic stem cell:	n/a	n/a
24	GABPA	chr19:41595917-41596221	H1-hESC	embryonic stem cell:	n/a	n/a
25	GTF2F1	chr19:41596095-41596124	H1-hESC	embryonic stem cell:	n/a	n/a
26	JUND	chr19:41595610-41596056	H1-hESC	embryonic stem cell:	n/a	chr19:41595791-41595803
27	JUND	chr19:41596089-41596245	H1-hESC	embryonic stem cell:	n/a	n/a
28	MAX	chr19:41596026-41596226	H1-hESC	embryonic stem cell:	n/a	n/a
29	MAX	chr19:41595820-41596368	H1-hESC	embryonic stem cell:	n/a	n/a
30	MAX	chr19:41595767-41596291	H1-hESC	embryonic stem cell:	n/a	n/a
31	MYC	chr19:41594857-41594861	MCF-7	breast:	n/a	n/a
32	MYC	chr19:41594863-41594913	MCF-7	breast:	n/a	n/a
33	MYC	chr19:41595927-41596005	H1-hESC	embryonic stem cell:	n/a	n/a
34	MYC	chr19:41592709-41592733	MCF-7	breast:	n/a	n/a
35	MYC	chr19:41594875-41594907	MCF-7	breast:	n/a	n/a
36	NR3C1	chr19:41589473-41589900	A549	lung:	n/a	n/a
37	POLR2A	chr19:41594856-41594966	MCF-7	breast:	n/a	n/a
38	POLR2A	chr19:41594893-41594908	MCF-7	breast:	n/a	n/a
39	POLR2A	chr19:41596028-41596277	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr19:41595995-41596011	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr19:41595897-41596130	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr19:41595933-41596401	H1-hESC	embryonic stem cell:	n/a	n/a
43	RAD21	chr19:41595862-41596225	H1-hESC	embryonic stem cell:	n/a	n/a
44	RAD21	chr19:41595752-41596300	H1-hESC	embryonic stem cell:	n/a	chr19:41596230-41596240
45	RAD21	chr19:41595915-41596325	H1-hESC	embryonic stem cell:	n/a	chr19:41596230-41596240
46	SIN3A	chr19:41595963-41596240	H1-hESC	embryonic stem cell:	n/a	n/a
47	TEAD4	chr19:41595954-41596417	H1-hESC	embryonic stem cell:	n/a	n/a
48	ZNF143	chr19:41595995-41596226	H1-hESC	embryonic stem cell:	n/a	n/a

(count:490 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41596066-41596116	ProgFib	skin:	n/a
2	chr19:41593461-41593511	SK-N-MC	brain:	n/a
3	chr19:41596066-41596116	ProgFib	skin:	n/a
4	chr19:41593461-41593511	SK-N-MC	brain:	n/a
5	chr19:41595977-41596027	NHDF-neo	bronchial:	n/a
6	chr19:41593202-41593252	HepG2	liver:	n/a
7	chr19:41593202-41593252	HRPEpiC	eye:	n/a
8	chr19:41593461-41593511	ProgFib	skin:	n/a
9	chr19:41596066-41596116	HIPEpiC	eye:	n/a
10	chr19:41594746-41594796	MCF10A-Er-Src	breast:	n/a
11	chr19:41595977-41596027	SK-N-SH	brain:	n/a
12	chr19:41596486-41596536	H1-hESC	embryonic stem cell:	embryo
13	chr19:41593995-41594045	HUVEC	blood vessel:	n/a
14	chr19:41593202-41593252	GM19239	blood:	n/a
15	chr19:41593461-41593511	HIPEpiC	eye:	n/a
16	chr19:41595975-41596025	U87	brain:	n/a
17	chr19:41595975-41596025	AG09319	gingival:	n/a
18	chr19:41593995-41594045	SK-N-SH_RA	brain:	n/a
19	chr19:41593202-41593252	LNCaP	prostate:	n/a
20	chr19:41595977-41596027	PFSK-1	brain:	n/a
21	chr19:41594746-41594796	Hela-S3	cervix:	n/a
22	chr19:41593461-41593511	HRCEpiC	kidney:	n/a
23	chr19:41593461-41593511	NT2-D1	testis:	n/a
24	chr19:41596066-41596116	MCF10A-Er-Src	breast:	n/a
25	chr19:41595975-41596025	GM06990	blood:	n/a
26	chr19:41593995-41594045	HNPCEpiC	eye:	n/a
27	chr19:41594746-41594796	GM12878	blood:	n/a
28	chr19:41596066-41596116	Hepatocyte	liver:	n/a
29	chr19:41594746-41594796	HCM	heart:	n/a
30	chr19:41595977-41596027	Hela-S3	cervix:	n/a
31	chr19:41596066-41596116	NT2-D1	testis:	n/a
32	chr19:41596486-41596536	HEEpiC	esophagus:	n/a
33	chr19:41594746-41594796	GM06990	blood:	n/a
34	chr19:41594746-41594796	HUVEC	blood vessel:	n/a
35	chr19:41594746-41594796	SAEC	small airway:	n/a
36	chr19:41595975-41596025	K562	blood:	n/a
37	chr19:41593461-41593511	HAEpiC	amniotic membrane:	n/a
38	chr19:41595975-41596025	A549	lung:	n/a
39	chr19:41596486-41596536	PANC-1	pancreas:	n/a
40	chr19:41595977-41596027	GM19239	blood:	n/a
41	chr19:41595977-41596027	HCF	heart:	n/a
42	chr19:41596486-41596536	RPTEC	kidney:	n/a
43	chr19:41596066-41596116	GM06990	blood:	n/a
44	chr19:41596066-41596116	SK-N-SH	brain:	n/a
45	chr19:41596486-41596536	SK-N-SH_RA	brain:	n/a
46	chr19:41595975-41596025	SK-N-MC	brain:	n/a
47	chr19:41595975-41596025	HRE	kidney:	n/a
48	chr19:41596066-41596116	K562	blood:	n/a
49	chr19:41596066-41596116	GM12891	blood:	n/a
50	chr19:41595975-41596025	PFSK-1	brain:	n/a

No data

Variant related genes	Relation type
CYP2A13	TF binding region
CYP2A13	CpG island

Extended variants
information (count: 647 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:647 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs73563325	chr19:41589907-41589908	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs563563790	chr19:41589918-41589919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs370013079	chr19:41589957-41589958	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs180891664	chr19:41589982-41589983	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs185476551	chr19:41589983-41589984	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs374146486	chr19:41589990-41589991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs546023276	chr19:41590043-41590044	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs565086882	chr19:41590047-41590048	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs550297189	chr19:41590063-41590064	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs377273228	chr19:41590076-41590077	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs551120385	chr19:41590077-41590078	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs560178039	chr19:41590091-41590092	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs527362323	chr19:41590111-41590112	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs549086382	chr19:41590148-41590149	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs569074176	chr19:41590158-41590159	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs529871948	chr19:41590164-41590165	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs370808755	chr19:41590185-41590186	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs305992	chr19:41590207-41590208	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs11272606	chr19:41590224-41590225	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs78107598	chr19:41590236-41590237	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs373880312	chr19:41590238-41590239	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs58655056	chr19:41590239-41590240	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs4802106	chr19:41590240-41590241	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs4802107	chr19:41590241-41590242	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs199551815	chr19:41590244-41590245	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs78444780	chr19:41590246-41590247	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs551289541	chr19:41590248-41590249	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs200845631	chr19:41590249-41590250	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs146742025	chr19:41590256-41590257	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs140432009	chr19:41590289-41590290	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs71175669	chr19:41590292-41590293	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs539803552	chr19:41590321-41590322	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs145417494	chr19:41590331-41590332	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs375941435	chr19:41590405-41590406	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs188277377	chr19:41590448-41590449	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs77428106	chr19:41590460-41590461	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs182013917	chr19:41590477-41590478	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs573490227	chr19:41590499-41590500	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs138065778	chr19:41590500-41590501	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs556019826	chr19:41590591-41590592	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs370544659	chr19:41590607-41590608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs369784433	chr19:41590646-41590647	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs545303562	chr19:41590651-41590652	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs559866787	chr19:41590657-41590658	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs527286270	chr19:41590661-41590662	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs28754360	chr19:41590673-41590674	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs542321041	chr19:41590690-41590691	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs561008006	chr19:41590697-41590698	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs140764451	chr19:41590710-41590711	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs558557234	chr19:41590717-41590718	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:66 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41586400-41594800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:41589400-41590000	Enhancers	HSMMtube	muscle
3	chr19:41591000-41591200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr19:41591000-41592600	Enhancers	Liver	Liver
5	chr19:41591600-41591800	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
6	chr19:41592000-41592400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr19:41592600-41595800	Weak transcription	Liver	Liver
8	chr19:41594000-41594200	Bivalent/Poised TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr19:41595200-41596600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
10	chr19:41595400-41595600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
11	chr19:41595400-41595600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
12	chr19:41595400-41595600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
13	chr19:41595400-41595800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
14	chr19:41595400-41595800	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
15	chr19:41595400-41596400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
16	chr19:41595400-41596400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
17	chr19:41595400-41596400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
18	chr19:41595400-41596400	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
19	chr19:41595400-41596600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
20	chr19:41595400-41596600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
21	chr19:41595600-41595800	Bivalent Enhancer	Brain Germinal Matrix	brain
22	chr19:41595600-41596200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
23	chr19:41595600-41596400	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr19:41595600-41596400	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
25	chr19:41595600-41596800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
26	chr19:41595800-41596000	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr19:41595800-41596000	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
28	chr19:41595800-41596000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
29	chr19:41595800-41596000	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
30	chr19:41595800-41596000	Bivalent Enhancer	Fetal Brain Female	brain
31	chr19:41595800-41596000	Bivalent/Poised TSS	A549	lung
32	chr19:41595800-41596200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
33	chr19:41595800-41596200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr19:41595800-41596200	Enhancers	Liver	Liver
35	chr19:41595800-41596200	Bivalent Enhancer	Placenta	Placenta
36	chr19:41595800-41596200	Enhancers	Ovary	ovary
37	chr19:41595800-41596200	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
38	chr19:41595800-41596400	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr19:41595800-41596400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
40	chr19:41595800-41596600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
41	chr19:41595800-41596600	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr19:41596000-41596200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr19:41596000-41596200	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
44	chr19:41596000-41596200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr19:41596000-41596200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr19:41596000-41596200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr19:41596000-41596200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr19:41596000-41596200	Bivalent Enhancer	Esophagus	oesophagus
49	chr19:41596000-41596200	Bivalent Enhancer	Fetal Intestine Large	intestine
50	chr19:41596000-41596200	Bivalent Enhancer	Fetal Muscle Trunk	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links